Question 1
What is the required temperature in a Containment Segregated Compounding Area (C-SCA)?
Correct Answer:
20 degrees C
Explanation:
In a Containment Segregated Compounding Area (C-SCA), the required temperature is set to 20 degrees Celsius. This temperature is in alignment with guidelines to ensure that compounded sterile preparations are performed in an environment that minimizes the risk of contamination and maintains the stability of the compounded products. Maintaining a temperature around 20 degrees Celsius helps to create an optimal environment for the manipulation of hazardous drugs, as it is cool enough to reduce the growth of microorganisms while also being practical for the comfort of personnel involved in the compounding process. This requirement is part of broader standards to create a controlled environment in compounding facilities, which helps prevent spoilage or degradation of sterile products due to temperature fluctuations. If the temperature is too low or too high, it can compromise both the safety and efficacy of the preparations being made.
Question 2
Which chapter of USP deals primarily with radiopharmaceuticals?
Correct Answer:
USP 823
Explanation:
The correct answer is USP 823 because this chapter specifically addresses the handling and compounding of radiopharmaceuticals, which are drugs that emit radiation and are used primarily for diagnostic or therapeutic purposes in nuclear medicine. USP 823 outlines the standards and requirements for the preparation of these highly specialized compounds, ensuring safety, quality, and efficacy in the handling of radioactive materials. This chapter also provides guidelines for various aspects, including personnel qualifications, environmental controls, and equipment requirements tailored to the unique challenges posed by working with radiopharmaceuticals. Given the complexity and potential hazards associated with radioactivity, these guidelines are critical in a sterile compounding environment to protect both patients and healthcare professionals. Other chapters mentioned, like USP 797 or USP 800, focus on sterile compounding and hazardous drugs, respectively, but do not specifically address the unique considerations for radiopharmaceuticals. USP 999, while a real designation, does not pertain to any established standards related to radiopharmaceuticals or sterile compounding. Therefore, USP 823 serves as the appropriate regulatory framework for handling radiopharmaceuticals in a compounding setting.
Question 3
Why is terminal filtration by membrane filtration preferred over direct inoculation?
Correct Answer:
It reduces the risk of contamination
Explanation:
Terminal filtration by membrane filtration is preferred over direct inoculation primarily because it significantly reduces the risk of contamination in the final product. In sterile compounding, maintaining the sterility of the preparation is paramount to ensure patient safety and effective treatment outcomes. When using membrane filtration, a sterile solution is passed through a filter that allows the passage of the solution while retaining microbial contaminants. This method effectively contains any potential contaminants present in the solution before it reaches the final container, thus ensuring the sterility of the compounded preparation. It effectively acts as a final barrier against bacteria, fungi, and other pathogens, allowing for a high degree of confidence in the sterility of the end product. Conversely, direct inoculation methods introduce microorganisms directly into the culture media, which could lead to an oversight of contaminants that may be present in the preparation. While it may be useful for certain quality control tests, it does not provide the same level of assurance regarding the absence of contaminants as membrane filtration does. In terms of the other options, terminal filtration does not necessarily lead to faster results, is not necessarily less expensive, and may involve a level of complexity that is comparable to other methods, making the filtration process just as easy or challenging depending on the setup. Therefore, the focus on
Question 4
What role does visual inspection serve in quality assurance for compounded preparations?
Correct Answer:
It identifies visible signs of contamination or inconsistencies
Explanation:
Visual inspection plays a crucial role in quality assurance for compounded preparations by identifying visible signs of contamination or inconsistencies. This step is vital in ensuring the safety and efficacy of the compounded products prior to dispensing. Through visual inspection, practitioners can observe the preparation for any particulate matter, discoloration, phase separation, or cloudiness, which may indicate contamination or improper formulation. These visual cues can reveal whether the compounding process was conducted correctly and if the final product meets the established quality standards. This inspection is an essential part of the overall quality assurance process, allowing pharmacists to ensure that the compounded preparation is suitable for patient use. While other processes like labeling and checking for odor may be important, they do not specifically focus on the physical integrity and safety of the compounded product in the same manner that visual inspection does. The emphasis is on safeguarding against potential risks that might arise from unnoticed contamination or inconsistencies in the preparation, which could significantly impact patient outcomes.
Question 5
What does the term "sterility assurance level" (SAL) refer to?
Correct Answer:
The effectiveness of sterilization in ensuring no viable organisms remain
Explanation:
The term "sterility assurance level" (SAL) specifically refers to the effectiveness of a sterilization process in ensuring that no viable organisms remain in a product after sterilization. It is a critical parameter in sterile compounding, as it quantifies the risk of a viable microorganism surviving the sterilization process. In practical terms, an SAL of 10^-6, for instance, indicates that there is only a one-in-a-million chance of a viable organism remaining in the final product, thereby providing a high level of assurance that the product is sterile. This concept is crucial in ensuring patient safety when administering sterile products, as even a single viable organism could lead to serious infections or complications. Understanding SAL is vital for compounding pharmacists, as it underscores the importance of following validated sterilization methods and maintaining stringent quality control measures during the compounding process.
Question 1
Exam overview

About this Exam

The Compounded Sterile Preparations Pharmacy (BCSCP) certification is the premier credential for pharmacists specializing in the complex and critical field of sterile compounding. Managed by the Board of Pharmacy Specialties (BPS), this certification validates that a pharmacist possesses advanced knowledge, skills, and expertise necessary to ensure the quality, safety, and efficacy of sterile medications. It is specifically designed for licensed pharmacists who oversee cleanroom operations, develop standard operating procedures, and perform or manage the preparation of compounded sterile preparations (CSPs). Earning the BCSCP designation demonstrates a practitioner's dedication to patient safety and adherence to rigorous regulatory standards.

More details

Additional Information

What the Course Entails and Exam Details

This specialized curriculum focuses intensely on the science and practice of developing sterile medication. Candidates are expected to master primary topics derived from the official BPS content outline, with a heavy emphasis on USP Chapter <797> (Sterile Preparations) and USP Chapter <800> (Hazardous Drugs). The course of study details the intricate designs of secondary engineering controls, the mechanics of primary engineering controls like laminar airflow workbenches, and the trending protocols required for environmental monitoring. Pharmacists must demonstrate proficiency in advanced sterile dosage calculations, beyond-use date (BUD) assignment based on stability and sterility testing, and strict aseptic manipulation techniques. Furthermore, the exam covers therapeutics and patient management concerning parenteral nutrition, hazardous drug handling, quality assurance programs, and regulatory compliance.


What to Expect in the Final Exam

The actual BPS Compounded Sterile Preparations Pharmacy examination is a rigorous, computer-based assessment consisting of multiple-choice questions. These questions are designed to test not only factual recall but also the critical application of aseptic principles in complex clinical scenarios. Candidates are typically given several hours to complete the examination, which is usually structured into two sessions separated by a scheduled break. While the exact number of questions may shift slightly between exam windows, initial certification exams generally feature 175 questions. BPS utilizes a scaled scoring system to maintain standard across different forms of the test, and a passing score represents the minimum level of knowledge required to practice competently in the specialty. It is crucial to remember that final exam questions reflect current pharmacy practice and updated USP standards.


How to Study and Exam Centers

Preparation for this exam requires a structured, multi-faceted approach combining didactic study with practical recall. Begin by analyzing the official BPS Examination Content Outline to identify core weaknesses. Focus your study efforts heavily on mastering the latest USP standards and sterilization principles. Professional organizations like the American Society of Health-System Pharmacists (ASHP) and the American Pharmacists Association (APhA) offer high-quality review courses and textbooks tailored to this specialty. To simulate the test-taking experience and improve time management, it is strongly recommended to utilize third-party BPS Sterile Compounding Practice Exams. Practice exams help you identify gaps in your knowledge and get comfortable with the clinical-case format of the questions.

The BPS specialty certification examinations are administered by appointment at authorized computer-based testing centers worldwide. BPS currently partners with Pearson VUE to manage these facilities. After submitting an application and receiving an Authorization to Test (ATT) from BPS, candidates can locate a convenient Pearson VUE test center via their website. Because testing centers can fill up quickly during peak exam windows, it is essential to schedule your examination date as early as possible once you receive approval.


Job Opportunities from the Course

Earning the BCSCP designation is a powerful career catalyst, opening doors to high-impact leadership roles within health systems, home infusion companies, and specialized compounding facilities. The certification validates your expertise to employers and enhances your value as a key player in patient safety and regulatory compliance.

Key job opportunities unlocked by this certification include:

  • Director of Sterile Compounding

  • Cleanroom Supervisor/Manager

  • Clinical Pharmacist Specialist (Sterile Preparations)

  • Pharmacy Quality Assurance Manager

  • Home Infusion Pharmacist Specialist

  • Pharmacy Compliance Officer

  • Manager of 503B Outsourcing Facilities

  • Sterile Compounding Educator or Instructor

  • Pharmacy Informatics Specialist (Sterile Workflow Technology)

  • Corporate Sterile Compounding Surveyor or Auditor



I have designed a comprehensive, SEO-optimized study guide for the BPS Sterile Compounding Exam, using professional educational copywriting to help candidates prepare. Each section provides actionable insights, from breaking down the critical USP guidelines covered in the syllabus to explaining the logistical details of scheduling your test with Pearson VUE. I have also prioritized high-readability formatting with clear spacing so you can easily reference this material during your studies. Good luck as you prepare for this career-advancing certification!

Quiz information

Frequently Asked Questions

The complete question count is available after full access is unlocked.
No fixed duration is currently configured for this quiz.
Question explanations are included where they are available in the quiz content, helping you review the reasoning after answering.
Yes. You can retake the practice test again as you continue studying during your available access period.
After your access is confirmed, you can continue into the complete practice exam from this quiz flow.
Unless explicitly stated otherwise, this page provides independent practice material for study and exam preparation and is not the official examination itself.
Keep studying

Related Questions